Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inhalation therapy: new delivery systems.

V V Ranade1

  • 1Rush-Presbyterian-St. Luke's Center, Rush University, Department of Pharmacology, Chicago, Illinois 60612-3515, USA.

American Journal of Therapeutics
|September 11, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bioavailability and pharmacokinetics of magnesium after administration of magnesium salts to humans.

American journal of therapeutics·2001
Same author

Mono- and bis(aminomethyl)phenylacetic acid esters as short-acting antiarrhythmic agents. 2.

Journal of medicinal chemistry·1993
Same author

Studies of serum gentamicin disposition after parenteral administration in ewes.

Hindustan antibiotics bulletin·1993
Same author

Significance of cholesterol in health and disease.

International journal of clinical pharmacology, therapy, and toxicology·1993
Same author

Safety assessment of injectable neomycin in calves.

Hindustan antibiotics bulletin·1992
Same author

Drug delivery systems. 6. Transdermal drug delivery.

Journal of clinical pharmacology·1991
Same journal

Deucravacitinib for Generalized Pustular Psoriasis and Comorbid Polymyositis: Dual Efficacy and Favorable Safety.

American journal of therapeutics·2026
Same journal

Repurposed Drugs and Cardiovascular Morbidity: A Cost-Effectiveness Analysis.

American journal of therapeutics·2026
Same journal

Do Not Treat a Sequencing Report: Therapeutic Stewardship in Endometrial Microbiome Testing.

American journal of therapeutics·2026
Same journal

Right Side Accessory Pathway Mediated Cardiomyopathy Treated with Amiodarone: First Adult Case Report.

American journal of therapeutics·2026
Same journal

Dose-Dependent Escitalopram-Induced Anejaculation and Anorgasmia: Rapid Reversal After Discontinuation and Bupropion Therapy.

American journal of therapeutics·2026
Same journal

Critical Appraisal of "Continued versus Interrupted Oral Anticoagulation During Transcatheter Aortic Valve Replacement in Patients with Atrial Fibrillation: A Meta-Analysis".

American journal of therapeutics·2026
See all related articles

This review covers recent advances in inhalation drug delivery, discussing devices, agents, and pulmonary delivery challenges. It critically appraises current methods and outlines future research directions for inhaled therapeutics and aerosols.

Area of Science:

  • Pulmonary Drug Delivery
  • Inhalation Technology
  • Aerosol Science

Background:

  • Inhalation drug delivery offers a direct route for pulmonary administration.
  • Various devices and therapeutic agents are utilized for inhaled treatments.
  • Understanding device-specific challenges and advantages is crucial for effective drug delivery.

Purpose of the Study:

  • To provide a comprehensive overview of recent advancements in inhalation drug delivery.
  • To discuss the problems, advantages, and limitations of current inhalation devices and agents.
  • To critically appraise the state of pulmonary drug delivery and outline future research avenues.

Main Methods:

  • Literature review of recent developments in inhalation devices.
  • Analysis of therapeutic agents used for pulmonary delivery.

Related Experiment Videos

  • Critical appraisal of existing data on inhalation drug delivery efficacy and challenges.

    • Main Results:

    • Recent advances have improved the efficacy and targeting of inhaled therapeutics.
    • Different inhalation devices present unique advantages and limitations.
    • Challenges remain in optimizing aerosol properties and device performance for consistent pulmonary deposition.

    Conclusions:

    • Continued innovation in inhalation devices and aerosol science is essential for advancing pulmonary drug delivery.
    • Future research should focus on personalized inhalation therapies and novel drug formulations.
    • Addressing current limitations will enhance the therapeutic potential of inhaled medications.